Curious to see your top suppliers emissions?
Book a demo for a pilot project
Sopharma AD
Pharmaceutical Preparation ManufacturingBulgaria
Last verified 11 months agosopharmagroup.com
Sopharma AD, a leading pharmaceutical company headquartered in Bulgaria (BG), has been a significant player in the healthcare industry since its establishment in 1996. With a strong presence in Eastern Europe and beyond, Sopharma focuses on the development, production, and distribution of a wide range of medicinal products, including generic drugs, over-the-counter medications, and active pharmaceutical ingredients.
Renowned for its commitment to quality and innovation, Sopharma AD has achieved notable milestones, including the expansion of its manufacturing capabilities and the introduction of several patented formulations. The company’s core products are distinguished by their efficacy and affordability, catering to diverse therapeutic areas. As a prominent entity in the pharmaceutical sector, Sopharma continues to enhance its market position through strategic partnerships and a robust portfolio, contributing to improved healthcare outcomes across its operational regions.
20
DitchCarbon score
-20 vs industry average
Sopharma AD’s score of 20 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sopharma AD?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Sopharma AD yet.
Sopharma AD's reported carbon emissions
Sopharma AD, headquartered in Bulgaria (BG), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any documented reduction targets or climate pledges, which limits the available information on their climate commitments.
As of now, Sopharma AD does not inherit emissions data from any parent or related organisations, and all available data is sourced directly from the company itself. Without specific emissions data or reduction initiatives, it is challenging to assess their environmental impact or commitment to climate action within the pharmaceutical industry context.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sopharma AD’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sopharma AD yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Sopharma AD11 months ago
20
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more